Skip to main content
. 2020 Jan 8;21(2):399. doi: 10.3390/ijms21020399
ASPI Arachidonic acid
AUC Area under the curve
CVD Cardiovascular diseases
ED endocrine disruptors
LC/MS/MS liquid chromatography-mass spectrometry
LOQ limit of quantification
MC540 Merocyanine 540
PC Phosphatidylcholine
PFAS Perfluoro–alkyl substances;
PFOA Perfluoro–octanoic acid
PFOS Perfluoro–octane–sulfonate
TRAP-6 Thrombin receptor activator peptide 6
ADP Adenosine diphosphate